NMS Capital announced that it has formed Flourish Research, which aims to become a leading, nationwide network of clinical research sites with therapeutic area and clinical trial phase diversity. For its initial investment in Flourish Research, NMS has completed the recapitalization of Clinical Trials of Texas in partnership with Founder Kay Scroggins and company management. Terms of the transaction were not disclosed. Read more.
Related Posts
UnitedHealth Pours $5M into Enable Ventures
The investment will back companies that can create better quality of life, offer resources to entrepreneurs with disabilities and provide support to people with disabilities who are unemployed or underemployed.
October 26, 2023
Antidote Health Harvests $12M Seed Round: Report
Investors included iAngels, Well-Tech Ventures, and Flint Capital.
August 26, 2021
Digital Health Acquisition Hacks 33% Off Deal Size Ahead of $100M IPO
The new SPAC will target a technology or healthcare focused business with an aggregate enterprise value of approximately $175 million to $500 million.
October 29, 2021
Tele911 Secures a Multimillion-Dollar Seed Round to Deploy Virtual Care into EMS
Tele911 integrates telemedicine and patient navigation into local EMS systems.
November 12, 2021